USHIFU, LLC Names New Chief Executive Officer
1/9/2012 6:25:41 AM
More...
|
USHIFU, LLC Release: Results Promising From U.K. Clinical Trial Investigating Sonablate HIFU as a Focal Treatment for Prostate Cancer
4/28/2011 11:42:48 AM
More...
|
USHIFU, LLC Acquires European Distribution Rights of the Sonablate(R) 500 Medical Device and Ownership of the Sonatherm(R) 600 Medical Device
5/28/2010 9:19:30 AM
More...
|
Misonix Incorporated (MSON) Announces Sale of Focus Surgery Related HIFU Business and Other HIFU Assets to USHIFU, LLC
5/28/2010 9:13:47 AM
More...
|
Misonix Incorporated (MSON) Announces Sale of Focus Surgery Related HIFU Business and Other HIFU Assets to USHIFU, LLC For Up To $5.8 Million
5/28/2010 9:09:23 AM
More...
|
USHIFU, LLC Secures $5 Million Financing From MMV Financial
7/29/2009 9:40:08 AM
More...
|
USHIFU, LLC Appoints Mark Schoenberg, M.D. Chief Medical Officer
2/10/2009 11:00:02 AM
More...
|
USHIFU, LLC Announces First Sonablate(R) HIFU Device in India for Minimally Invasive Prostate Cancer Treatment
12/2/2008 10:25:40 AM
More...
|
USHIFU, LLC High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
9/12/2008 7:43:04 AM
More...
|
USHIFU, LLC Release: Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments
7/10/2008 10:24:40 AM
More...
|
|